Introduction {#S0001}
============

Chronic kidney disease (CKD) is a global health problem, and its prevalence and incidence have gradually increased.[@CIT0001],[@CIT0002] It has also been recognized as an independent risk factor for both cardiovascular complications and all-cause mortality in a wide spectrum of clinical scenarios.[@CIT0002]--[@CIT0007] The national prevalence of CKD for adults aged 20 years and older over the period from 1994 to 2006 in Taiwan was approximately 11.9%.[@CIT0008] In the United States, the prevalence of CKD stages 1--5 during the 2011--2014 period reached 14.8%,[@CIT0001] which was 1.23 times higher when compared with that in the 1988--1994 period.[@CIT0001] Particularly, the largest increase was observed in stage 3 CKD (from 4.5% to approximately 6.5%), which has become the most prevalent stage.[@CIT0001] Though the exact pathophysiology for postoperative morbidity and mortality is still unknown, elevated levels of inflammatory mediators, plasma homocysteine, endothelial dysfunction, hypercoagulability, and arterial calcification may all serve important roles.[@CIT0005],[@CIT0006],[@CIT0009]--[@CIT0014]

Associated comorbidities, including diabetes mellitus, hypertension, hyperlipidemia, or cardiac diseases,[@CIT0001],[@CIT0005],[@CIT0006],[@CIT0008] may complicate CKD, in terms of surgical outcomes.[@CIT0005],[@CIT0015] In several widely used surgical risk indices, kidney dysfunction has often been listed as a major predictive factor.[@CIT0005],[@CIT0016],[@CIT0017] In view of the potentially increased absolute number of CKD patients, these patients are more likely to undergo various surgical procedures.

Renal function impairment represents a wide variety of complex diseases1,[@CIT0008],[@CIT0015] that may have differential impacts on postoperative adverse outcomes.[@CIT0003]--[@CIT0005],[@CIT0018] Although the perioperative outcomes of surgical risks in patients with CKD have been reported,[@CIT0003]--[@CIT0005],[@CIT0009] there were several limitations in the previous studies, such as small sample size,[@CIT0003],[@CIT0009],[@CIT0019],[@CIT0020] inadequate adjustments for potential confounders,[@CIT0009],[@CIT0019]--[@CIT0022] and focus on a single surgical procedure or a specific population.[@CIT0004],[@CIT0009],[@CIT0019]--[@CIT0022] These previous studies indicated that the association between preoperative CKD and postoperative adverse events was not completely understood. By using Taiwan's National Health Insurance Research Database, we conducted a matched nationwide analysis to evaluate the global features of complications and mortality after various major surgeries in individuals with and without CKD.

Methods {#S0002}
=======

Source of data {#S0002-S2001}
--------------

Taiwan's National Health Insurance program was implemented in March 1995, with a high coverage of more than 99% of Taiwan's 23 million residents. This study used reimbursement claims data from Taiwan's National Health Insurance Research Database that recorded all of the beneficiaries' medical services, including inpatient and outpatient demographic characteristics, the physicians' primary and secondary diagnoses, treatment procedures, prescriptions, and medical expenditures.

Ethical approval {#S0002-S2002}
----------------

To protect personal privacy, the electronic database was coded with patient identification scrambled for further public access for research. According to the National Health Research Institutes regulations, informed consent is not required because of the use of coded and scrambled patient identification. Our study was conducted in accordance with the Helsinki Declaration, and it was also approved by Taiwan's National Health Research Institutes and the institutional review board of Taipei Medical University (TMU-JIRB-201808012; TMU-JIRB-201509050).

Study design {#S0002-S2003}
------------

We identified 35,643 patients with CKD, aged 20 years and older, who underwent major nonurological surgical procedures from January 1, 2008, through December 31, 2013. These procedures required general, epidural, or spinal anesthesia as well as hospitalization for at least 1 day. Each surgical patient with CKD was matched with 1 randomly selected, non-CKD surgical patient. We conducted the analysis by using a propensity-score-matched pair procedure and considered the following factors: age, sex, low income or not, whether the operation took place in a medical center, coexisting medical conditions, preoperative emergency care, preoperative inpatient care, types of nonurological surgeries, and types of anesthesia. To identify patients with CKD strictly, the present study required at least medical visits with a physician's primary diagnosis of CKD within the 24-month preoperative period. People without CKD were defined as those who had no medical visits with a physician's primary or secondary diagnosis of CKD within the 24-month preoperative period.

Measures and definitions {#S0002-S2004}
------------------------

The patients' income statuses were identified from the Taiwan National Health Insurance Bureau, which defined low income as an economic status that qualified for waived medical copayments when receiving medical services. Whether the surgery was performed in a medical center and the types of nonurological surgeries and anesthesia were also recorded. The International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) was used to define the clinical diagnoses. Based on previous surgical studies, the medical conditions that were determined from the reimbursement claims for the 24-month preoperative period included mental disorders (ICD-9-CM 290--319), chronic obstructive pulmonary disease (ICD-9-CM 490--496), hypertension (ICD-9-CM 401--405), diabetes (ICD-9-CM 250), hyperlipidemia (ICD-9-CM 272.0, 272.1, and 272.2), ischemic heart disease (ICD-9-CM 410--414), epilepsy (ICD-9-CM 345), liver cirrhosis (ICD-9-CM 571), and heart failure (ICD-9-CM 428).

In-hospital mortality after the index surgery was considered to be the study's primary outcome. Nine major postoperative complications were considered to be secondary outcomes and included septicemia (ICD-9-CM 038 and 998.5), stroke (ICD-9-CM 430--437) pneumonia (ICD-9-CM 480--486), urinary tract infection (ICD-9-CM 599.0), acute myocardial infarction (ICD-9-CM 410), postoperative bleeding (ICD-9-CM 998.0, 998.1, and 998.2), and pulmonary embolism (ICD-9-CM 415). The incidences of intensive care, lengths of hospital stay, and medical expenditures during the index surgical admission were also compared. In this study, surgical patients who had septicemia, stroke, pneumonia, urinary tract infection, acute myocardial infarction, surgical bleeding, and pulmonary embolism within preoperative 3 months were not considered as those had postoperative complications.

Statistical analyses {#S0002-S2005}
--------------------

For the determination of the associations between CKD and the postoperative outcomes, we used a nonparsimonious multivariable logistic regression model to estimate a propensity score for each of the surgical patients with CKD or without CKD. Clinical significance guided the initial choice of the covariates in this model to include age, sex, low-income status, whether the operation took place in a medical center, types of surgery and anesthesia, hypertension, diabetes, cancer, mental disorders, peptic ulcer disease, chronic obstructive pulmonary disease, gout, anemia, atherosclerosis, pneumonia, asthma, osteoporosis, liver cirrhosis, angina, heart failure, venereal disease, Parkinson's disease, myocardial infarction, alcohol-related illness, peripheral vascular disease, atrial fibrillation, pulmonary tuberculosis, epilepsy, psoriasis, systemic lupus erythematosus, hypothyroidism, preoperative emergency care, and inpatient care.

We matched patients with CKD to non-CKD controls by using a greedy matching algorithm (without replacement) with a caliper width of 0.2 standard deviations of the log odds of the estimated propensity score. The categorical variables were summarized by using frequencies (percentages) and were compared between patients with and without CKD by using chi-square tests. The continuous variables were summarized by using means±standard deviations and were compared by using *t*-tests. Logistic regressions were used to calculate the adjusted odds ratios (ORs) and the 95% confidence intervals (CIs) of the postoperative outcomes that were associated with CKD. Additional analyses, which were stratified by age, sex, number of medical conditions, emergency visits, and hospitalizations, were also performed in order to examine the outcomes after nonurinary surgeries among patients with CKD within these strata.

Results {#S0003}
=======

The baseline characteristics of the patients with and without CKD who underwent major surgeries are shown in [Table 1](#T0002){ref-type="table"}. Under the propensity-score matching procedure ([Table 2](#T0003){ref-type="table"}), there were no significant differences in age, sex, low-income status, types of hospitals, surgery or anesthesia types, hypertension, diabetes, cancer, mental disorders, peptic ulcer disease, chronic obstructive pulmonary disease, gout, anemia, atherosclerosis, pneumonia, asthma, osteoporosis, liver cirrhosis, angina, heart failure, venereal disease, Parkinson's disease, myocardial infarction, alcohol-related illness, peripheral vascular disease, atrial fibrillation, pulmonary tuberculosis, epilepsy, psoriasis, systemic lupus erythematosus, hypothyroidism, number of hospitalizations, and emergency care between the patients with CKD and those patients without CKD.Table 1Characteristics of patients received nonurological surgeries with and without chronic kidney diseaseNo CKD (N=489,436)CKD (N=122,359)*P*n(%)n(%)Age, years\<0.0001 20--294736(1.0)1184(1.0) 30--3914,960(3.1)3740(3.1) 40--4939,760(8.1)9940(8.1) 50--5988,208(18.0)22,052(18.0) 60--69115,976(23.7)28,994(23.7) 70--79152,162(31.1)35,206(28.8) ≥8073,634(15.0)21,243(17.4)Sex1.0000 Female229,976(47.0)57,494(47.0) Male259,460(53.0)64,865(53.0)Low income\<0.0001 No479,230(97.9)115,838(94.7) Yes10,206(2.1)6521(5.3)Operation in medical center\<0.0001 No292,981(59.9)68,148(55.7) Yes196,455(40.1)54,211(44.3)Types of surgery\<0.0001 Musculoskeletal11,539(2.4)3661(3.0) Digestive8131(1.7)907(0.7) Neurosurgery176,298(36.0)34,909(28.5) Cardiovascular22,034(4.5)3577(2.9) Respiratory14,006(2.9)26,981(22.1) Skin126,124(25.8)25,499(20.8) Eye6525(1.3)313(0.3) Breast60,306(12.3)10,836(8.9) Delivery, CS, abortion6535(1.3)2325(1.9) Others57,938(11.8)13,351(10.9)Types of anesthesia\<0.0001 General350,831(71.7)97,402(79.6) Epidural or spinal138,605(28.3)24,957(20.4)Coexisting medical conditions Hypertension156,299(31.9)50,963(41.7)\<0.0001 Diabetes72,099(14.7)45,126(36.9)\<0.0001 Anemia21,626(4.4)30,086(24.6)\<0.0001 Mental disorders81,935(16.7)25,427(20.8)\<0.0001 Peptic ulcer disease54,820(11.2)23,675(19.4)\<0.0001 COPD61,406(12.6)17,760(14.5)\<0.0001 Cancer71,000(14.5)17,038(13.9)\<0.0001 Atherosclerosis23,342(4.8)15,708(12.8)\<0.0001 Gout25,172(5.1)14,300(11.7)\<0.0001 Pneumonia18,230(3.7)13,380(10.9)\<0.0001 Heart failure9213(1.9)12,342(10.1)\<0.0001 Angina15,391(3.1)7887(6.5)\<0.0001 Asthma27,408(5.6)7493(6.1)\<0.0001 Liver cirrhosis12,169(2.5)5406(4.4)\<0.0001 Myocardial infarction4073(0.8)4502(3.7)\<0.0001 Osteoporosis17,870(3.7)4316(3.5)0.0383 Parkinson's disease10,891(2.2)3608(3.0)\<0.0001 Venereal disease10,779(2.2)2785(2.3)0.1170 Peripheral vascular disease4583(0.9)2742(2.2)\<0.0001 Pulmonary tuberculosis4671(1.0)2337(1.9)\<0.0001 Alcohol-related illness7233(1.5)2204(1.8)\<0.0001 Atrial fibrillation3834(0.8)1763(1.4)\<0.0001 Epilepsy3167(0.7)1563(1.3)\<0.0001 Systemic lupus erythematosus847(0.2)1521(1.2)\<0.0001 Psoriasis3331(0.7)1245(1.0)\<0.0001 Hypothyroidism2159(0.4)885(0.7)\<0.0001Number of hospitalizations\<0.0001 0296,852(60.7)29,300(24.0) 1105,368(21.5)24,751(20.2) 243,012(8.8)19,178(15.7) ≥344,204(9.0)49,130(40.2)Number of emergency visits\<0.0001 0258,654(52.9)27,654(22.6) 1114,014(23.3)22,986(18.8) 254,457(11.1)18,017(14.7) ≥362,311(12.7)53,702(43.9)[^2] Table 2Characteristics of patients received nonurological surgeries with and without chronic kidney diseaseNo CKD (N=35,643)CKD (N=35,643)*P*n(%)n(%)Age, yearsn(%)n(%)1.0000 20--29223(0.6)223(0.6) 30--39848(2.4)848(2.4) 40--492789(7.8)2789(7.8) 50--596968(19.6)6968(19.6) 60--698816(24.7)8816(24.7) 70--7910,966(30.8)10,966(30.8) ≥805033(14.1)5033(14.1)Sex1.0000 Female16,851(47.3)16,851(47.3) Male18,792(52.7)18,792(52.7)Low income1.0000 No35,286(99.0)35,286(99.0) Yes357(1.0)357(1.0)Operation in medical center1.0000 No19,684(55.2)19,684(55.2) Yes15,959(44.8)15,959(44.8)Types of surgery1.0000 Musculoskeletal12,196(34.2)12,196(34.2) Digestive9075(25.5)9075(25.5) Neurosurgery3971(11.1)3971(11.1) Cardiovascular2937(8.2)2937(8.2) Respiratory742(2.1)742(2.1) Skin480(1.4)480(1.4) Eye394(1.1)394(1.1) Breast263(0.7)263(0.7) Delivery, CS, abortion111(0.3)111(0.3) Others5474(15.4)5474(15.4)Types of anesthesia1.0000 General27,580(77.4)27,580(77.4) Epidural or spinal8063(22.6)8063(22.6)Coexisting medical conditions Hypertension10,907(30.6)10,907(30.6)1.0000 Diabetes7543(21.2)7543(21.2)1.0000 Cancer4068(11.4)4068(11.4)1.0000 Mental disorders3863(10.8)3863(10.8)1.0000 Peptic ulcer disease2936(8.2)2936(8.2)1.0000 COPD1858(5.2)1858(5.2)1.0000 Gout1856(5.2)1856(5.2)1.0000 Anemia1824(5.1)1824(5.1)1.0000 Atherosclerosis903(2.5)903(2.5)1.0000 Pneumonia602(1.7)602(1.7)1.0000 Asthma554(1.6)554(1.6)1.0000 Osteoporosis434(1.2)434(1.2)1.0000 Liver cirrhosis353(1.0)353(1.0)1.0000 Angina372(1.0)372(1.0)1.0000 Heart failure303(0.9)303(0.9)1.0000 Venereal disease244(0.7)244(0.7)1.0000 Parkinson's disease223(0.6)223(0.6)1.0000 Myocardial infarction93(0.3)93(0.3)1.0000 Alcohol-related illness96(0.3)96(0.3)1.0000 Peripheral vascular disease67(0.2)67(0.2)1.0000 Atrial fibrillation38(0.1)38(0.1)1.0000 Pulmonary tuberculosis36(0.1)36(0.1)1.0000 Epilepsy28(0.1)28(0.1)1.0000 Psoriasis49(0.1)49(0.1)1.0000 SLE27(0.1)27(0.1)1.0000 Hypothyroidism30(0.1)30(0.1)1.0000Number of hospitalizations1.0000 018,344(51.5)18,344(51.5) 18903(25.0)8903(25.0) 23749(10.5)3749(10.5) ≥34647(13.0)4647(13.0)Number of emergency visits1.0000 015,573(43.7)15,573(43.7) 18719(24.5)8719(24.5) 24342(12.2)4342(12.2) ≥37009(19.7)7009(19.7)[^3]

Compared with the non-CKD controls ([Table 3](#T0004){ref-type="table"}), patients with CKD had higher risks of postoperative stroke (OR: 1.34, 95% CI: 1.24--1.44), pneumonia (OR: 1.60, 95% CI: 1.48--1.73), urinary tract infection (OR: 1.09, 95% CI: 1.01--1.17), septicemia (OR: 1.78, 95% CI: 1.68--1.89), admission to intensive care units (OR: 1.38, 95% CI: 1.32--1.43), and 30-day in-hospital mortality (OR: 2.17, 95% CI: 1.90--2.47). Longer lengths of stay (13.2±17.8 vs 11.0±16.5 days, respectively; *P*\<0.0001) and higher medical expenditures (4,598±5,700 vs 3,938±5,195 US dollars, respectively; *P*\<0.0001) were also noted in patients with CKD, compared to those patients without CKD.Table 3Risk of postoperative complications and mortality for surgical patients with preoperative CKDNo CKD (N=35,643)CKD (N=35,643)Risk of outcomesPostoperative outcomesEvents%Event%OR(95% CI)^a^30-day in-hospital mortality3461.07332.12.17(1.90--2.47)Postoperative complications Septicemia18185.130378.51.78(1.68--1.89) Stroke13743.917855.01.34(1.24--1.44) Pneumonia11413.217614.91.60(1.48--1.73) Urinary tract infection13823.914974.21.09(1.01--1.17) Acute myocardial infarction3631.03601.00.99(0.85--1.15) Postoperative bleeding2350.72750.81.17(0.98--1.40) Pulmonary embolism500.1320.10.64(0.41--1.00)ICU stay630117.7773221.71.38(1.32--1.43)Medical expenditure, USD^b^3938±51954598±5700*p*\<0.0001Length of hospital stay, days^b^11.0±16.513.2±17.8*p*\<0.0001[^4]

[Table 4](#T0005){ref-type="table"} shows that the associations between CKD and increased postoperative adverse events were significant for women, men, every age group, and patients with lower than 3 medical conditions. Postoperative adverse event was associated with CKD in patients with hospitalization and emergency care or not.Table 4Stratified analysis for the risk of postoperative adverse events in patients with and without CKDnPostoperative adverse events^a^EventsIncidence, %OR(95% CI)Age 20--29 yearsNo CKD22394.01.00(reference)CKD223219.42.65(1.15--6.11)Age 30--39 yearsNo CKD848263.11.00(reference)CKD848677.93.02(1.85--4.93)Age 40--49 yearsNo CKD27891916.91.00(reference)CKD278929610.61.66(1.37--2.02)Age 50--59 yearsNo CKD69685718.21.00(reference)CKD696893013.41.77(1.58--1.98)Age 60--69 yearsNo CKD8816103411.71.00(reference)CKD8816156717.81.66(1.52--1.81)Age 70--79 yearsNo CKD10,966187817.11.00(reference)CKD10,966253023.11.48(1.38--1.58)Age ≥80 yearsNo CKD5033123124.51.00(reference)CKD5033147229.31.30(1.18--1.42)FemaleNo CKD16,851204312.11.00(reference)CKD16,851300117.81.62(1.52--1.73)MaleNo CKD18,792289715.41.00(reference)CKD18,792388220.71.47(1.39--1.55)0 Medical conditionNo CKD10,549119511.31.00(reference)CKD10,549189418.01.76(1.62--1.90)1 Medical conditionNo CKD14,282195113.71.00(reference)CKD14,282273219.11.52(1.42--1.62)2 Medical conditionsNo CKD8016123315.41.00(reference)CKD8016161020.11.40(1.29--1.52)3 Medical conditionsNo CKD227644219.41.00(reference)CKD227650422.11.19(1.03--1.38)≥4 Medical conditionsNo CKD52011922.91.00(reference)CKD52014327.51.30(0.97--1.74)0 HospitalizationNo CKD18,344210111.51.00(reference)CKD18,344287815.71.47(1.38--1.57)1 HospitalizationNo CKD8903119413.41.00(reference)CKD8903175619.71.63(1.50--1.77)2 HospitalizationsNo CKD374959615.91.00(reference)CKD374988323.61.67(1.49--1.88)≥3 HospitalizationsNo CKD4647104922.61.00(reference)CKD4647136629.41.46(1.32--1.60)0 Emergency visitNo CKD15,573167410.81.00(reference)CKD15,573228114.71.45(1.36--1.56)1 Emergency visitNo CKD8719122214.01.00(reference)CKD8719171319.71.54(1.42--1.67)2 Emergency visitsNo CKD434266215.31.00(reference)CKD434297922.61.67(1.49--1.87)≥3 Emergency visitsNo CKD7009138219.71.00(reference)CKD7009191027.31.56(1.44--1.69)[^5]

After adjustments in the multivariate logistic regressions ([Table S1](#ST0001)), age (≥80 years; OR: 3.65, 95% CI: 2.28--5.83), the male sex (OR: 1.09, 95% CI: 1.03--1.15), and surgeries that did not occur in medical centers (OR: 1.13, 95% CI: 1.06--1.19), as well as incidences of neurosurgery (OR: 8.45, 95% CI: 5.16--13.8), general anesthesia (OR: 1.23, 95% CI: 1.14--1.33), myocardial infarction (OR: 2.17, 95% CI: 1.41--3.32), alcohol-related illness (OR: 1.88, 95% CI: 1.14--3.10), epilepsy (OR: 3.97, 95% CI: 1.77--8.92), Parkinson's disease (OR: 1.45, 95% CI: 1.08--1.94), diabetes (OR: 1.15, 95% CI: 1.07--1.23), ≥3 preoperative hospitalizations (OR: 1.74, 95% CI: 1.58--1.91), and ≥3 emergency visits (OR: 1.47, 95% CI: 1.36--1.60), were significant factors that were associated with postoperative adverse events among surgical patients with CKD.

Discussion {#S0004}
==========

By using a comprehensive study design that included matching by propensity score, a large sample size, a multivariate adjustment of confounders, and the inclusion of various types of surgery, we observed that patients with CKD had a nearly 2.5-fold higher postoperative 30-day in-hospital mortality and higher risk of complications, such as stroke, acute myocardial infarction, postoperative bleeding, pneumonia, urinary tract infection, and septicemia. In the CKD population, older age, low-income status, male sex, general anesthesia, and neurosurgery had relatively higher risks of postoperative mortality.

In this study, CKD is associated with postoperative mortality. A previous study suggested that the mortality in CKD patients is higher during hospitalization in other conditions as well especially in infections even without surgery.[@CIT0023] The postoperative mortality in patients with CKD differed in the various types of surgeries,[@CIT0003],[@CIT0004],[@CIT0009],[@CIT0019]--[@CIT0022] and the corresponding complication rate was associated with both the preoperative stage of CKD and the estimated glomerular filtration rate (eGFR).[@CIT0003],[@CIT0009],[@CIT0019],[@CIT0021],[@CIT0022] Our investigation focused on different types of surgical specialties, and the overall postoperative mortality was 2.6%. A previous meta-analysis suggested that most of the causes of postoperative death in CKD patients were due to cardiovascular adverse events, followed by septicemia.[@CIT0004] Among previous studies, cardiovascular and infectious adverse events commonly occurred in patients with CKD, but there still existed inconsistencies in these events, either in mortality rate or complication incidence.[@CIT0004],[@CIT0009],[@CIT0022] These observations can possibly be attributed to the different surgical procedures and varied severities of renal dysfunction.

Cardiovascular complications and associated death have been shown to be related to patients with renal function insufficiency.[@CIT0001]--[@CIT0003],[@CIT0006]--[@CIT0008] In our investigation, incidences of postoperative stroke and acute myocardial infarction were significantly higher in the CKD group. Although the exact mechanism for the development of postoperative cardiovascular events is still unknown, some hypotheses have been developed to explain the phenomena. For example, increased levels of inflammatory and prothrombotic markers, such as c-reactive protein, fibrinogen, albumin, hemoglobin, white blood cell counts, and coagulation factor VII, have been observed in cases of renal disease and decreased GFR.[@CIT0024],[@CIT0025] Other factors contributing to the abnormal cardiovascular outcomes included accelerated atherogenesis, nutritional effects, endothelial dysfunction, metabolic changes, coronary artery calcification, and left ventricle abnormalities.[@CIT0025]

Medical and surgical infections are common in patients with CKD.[@CIT0026]--[@CIT0029] In our investigation, pneumonia, septicemia, and urinary tract infection were remarkably major postoperative complications in patients with CKD. Although the probable pathophysiology for the association is still unclear, several potential mechanisms have been postulated. For example, more comorbid illnesses, declined vaccination responsiveness, increased inflammatory cytokine levels, higher serum c-reactive protein concentrations, albuminuria, degraded endothelial glycocalyx, and impaired host immunity were shown to be associated with different types of infectious adverse outcomes.[@CIT0026],[@CIT0027],[@CIT0030] However, the results were inconsistent between systemic infections (pneumonia and septicemia) and local infections in our study. Deep wound infections in patients with CKD did not exhibit significant differences when compared with the non-CKD group. A prior investigation of coronary artery bypass surgery in CKD patients revealed that wound infection rates were doubled in the moderate CKD group and that there was a more than 5-fold increase in the severe CKD group.[@CIT0029] Local wound infection was solely notably increased in advanced CKD,[@CIT0027],[@CIT0029] and the discrepancies between our investigation and previous investigations are possibly due to the limitation of staging status in the presenting database. We suggested that the prevention of infection in CKD patients is crucial because it may lead to increased risk of cardiovascular events, end-stage kidney disease, and mortality.[@CIT0031]

In the nonoperative condition, individuals with CKD had greater chances of bleeding.[@CIT0032] The possible mechanism was thought to be related to platelet dysfunction, an abnormal interaction between platelets and the vascular walls, anemia, or effects of certain drugs.[@CIT0032]--[@CIT0034] Nevertheless, the detailed risk for perioperative bleeding remains unclear. In our study, postoperative bleeding was significantly higher in patients with CKD than in the population without CKD. Our findings were similar with a previous meta-analysis, which revealed the increased risks of blood transfusion requirements and postoperative bleeding.[@CIT0032] CKD was also considered to be an independent risk factor for blood transfusion predictions.[@CIT0035] The postulated pathophysiology for the risk of postoperative bleeding is complicated and may be attributed to multiple defects in all of the steps of platelet aggregation.[@CIT0032],[@CIT0033] Abnormal platelet adhesion has been observed to be due to the functional derangement of the interaction between von-Willebrand factors and glycoproteins IIb-IIIa as well as increased production of prostacyclin and nitric oxide, which makes platelet activation in CKD patients difficult.[@CIT0034],[@CIT0036],[@CIT0037] Furthermore, inadequate platelet stores of adenosine diphosphate (ADP), as well as inadequate serotonin levels, cyclooxygenase defects, decreased thromboxane A~2~ synthesis, and altered calcium mobilization, also appear to be associated with bleeding diathesis.[@CIT0034],[@CIT0037]

There were some limitations that need to be addressed. First, we could not categorize the stage of CKD in this study because the information of glomerular filtration rate was not available in the database of Taiwan's National Health Insurance. The definition of CKD was based on physician's diagnosis during medical visits may cause misclassification because some people with mild CKD (such as stage 1 CKD) may not seek for medical care. This condition may lead to underestimation of the impact of CKD on perioperative outcome in this study because some mild CKD patients may exist in the non-CKD group in this study. Second, the administrative database lacked information on the individual characteristics of patients, such as socioeconomic condition, lifestyle, preoperative laboratory data, and pharmacological compliance. Third, the perioperative variables that were related to surgery and anesthesia were not adequately available in this research database, including factors such as changes in hemodynamic parameters, total volume of blood loss, transfusion details, use of prophylactic antibiotics or anticoagulants, duration of surgery, and postoperative meticulous care profiles. In addition, our study was of a retrospective nature, and a detailed randomization distribution could not be achieved between the groups, even though comprehensive matching and statistical adjustment were performed in this study. However, we assumed that the influence of all of the covariates was evenly distributed between the groups and that the bias would be reduced in this population-based, large-scale study. Finally, our study is based on ICD-9-CM codes and very few coding errors could not be avoided.

In conclusion, CKD was an independent risk factor for postoperative mortality and complications, and adverse events after surgery could be observed in the various subgroups. The comprehensive preoperative assessment and optimal control of correctable risk factors should be effectively and efficiently implemented in advance to achieve better outcomes.

Supplementary material {#S0008}
======================

Table S1Factors associated with adverse events after nonurological surgeries in patients with chronic kidney disease (N=35643)^a^OR(95% CI)Age, years20--291.00(reference)30--390.83(0.49--1.40)40--491.14(0.70--1.84)50--591.35(0.84--2.15)60--691.84(1.16--2.94)70--792.55(1.60--4.07)≥803.65(2.28--5.83)SexFemale1.00(reference)Male1.09(1.03--1.15)Operation in medical centerNo1.13(1.06--1.19)Yes1.00(reference)Types of surgeryMusculoskeletal3.39(2.07--5.54)Digestive5.27(3.22--8.62)Neurosurgery8.45(5.16--13.8)Cardiovascular8.03(4.89--13.2)Respiratory6.19(3.68--10.4)Skin4.89(2.85--8.39)Eye1.00(reference)Breast3.02(1.56--5.84)Delivery, CS, abortion3.87(1.58--9.52)Others2.73(1.66--4.50)Types of anesthesiaEpidural or spinal1.00(reference)General1.23(1.14--1.33)Myocardial infarctionYes vs no2.17(1.41--3.32)Alcohol-related illnessYes vs no1.88(1.14--3.10)Parkinson's diseaseYes vs no1.45(1.08--1.94)EpilepsyYes vs no3.97(1.77--8.92)DiabetesYes vs no1.15(1.07--1.23)Number of hospitalizations01.00(reference)11.18(1.10--1.26)21.38(1.25--1.51)≥31.74(1.58--1.91)Number of emergency visits01.00(reference)11.27(1.18--1.36)21.37(1.25--1.50)≥31.47(1.36--1.60)[^6]
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